ELISA diagnostic kit for cardiovascular biomarker measurement. Supports assessment of cardiac function and disease risk in clinical settings.
Manufactured by
Beijing, China
Hotgen Biotech Co.,Ltd was founded in 2005 and located in Biomedical Base of Zhongguancun High-Tech Park in Beijing. It is a national-level high-tech company dedicated to the development and manufacturing of innovative in-vitro diagnostic (IVD), point-of-care-testing (POCT) and biodefense products. Now Hotgen have 4 technology platforms: 1. Chemiluminescence Immunoassay CLIA System. ( MQ60 and MQ plus) Test parameters: 1) Cardiac: hs-cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2 2) Inflammation Monitoring: CRP, PCT, IL-6 3) Kidney Function: NG and other diagnostic markers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GenSure Biotech Inc.
China · 2 relevant products
ProGnosis Biotech S.A.
Greece · 1 relevant product
Nanjing Synthgene Medical Technology Co., Ltd.
China · 2 relevant products
87 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 108 closest product alternatives
GenSure Biotech Inc. · China
In vitro diagnostic test for detection of cardiac-related biomarkers indicating myocardial injury or cardiac function status. Supports cardiovascular risk assessment and acute coronary syndrome evaluation.
ProGnosis Biotech S.A. · Greece
ELISA-based diagnostic kit for cardiac marker detection in clinical cardiology applications. Advanced testing solution under development utilizing validated antigen-antibody technology.
Nanjing Synthgene Medical Technology Co., Ltd. · China
A diagnostic test for cardiac risk markers assessment in cardiovascular health evaluation. Detects biomarkers indicative of potential cardiac conditions.
105 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products